MELADININE

This brand name is authorized in France, Hong Kong, Malta, Tunisia

Active ingredients

The drug MELADININE contains one active pharmaceutical ingredient (API):

1 Methoxsalen UNII U4VJ29L7BQ - METHOXSALEN

Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (crosslinking of psoralen to both strands of DNA). Reactions with proteins have also been described. The formation of photoadducts results in inhibition of DNA synthesis, cell division and epidermal turnover. Read about Methoxsalen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AD02	Methoxsalen	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AD Psoralens for topical use
Discover more medicines within D05AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 60914559, 67527650, 69898864
Country: HK	Department of Health Drug Office	Identifier(s): 02975, 02976
Country: MT	Medicines Authority	Identifier(s): AA565/93001, AA729/26501
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 11363011